Cas 188124-80-3,D-Isovaline, 3-hydroxy-, ethyl ester, (4R)-rel- (9CI)

188124-80-3

Post Buying Request

Basic information

Product Name: D-Isovaline, 3-hydroxy-, ethyl ester, (4R)-rel- (9CI)
Synonyms: D-Isovaline, 3-hydroxy-, ethyl ester, (4R)-rel- (9CI)
CAS NO:188124-80-3
Molecular Formula: C7H15NO3
Molecular Weight: 161.1989
EINECS: N/A
Product Categories: GLYCINESCAFFOLD
Mol File: 188124-80-3.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: /
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: D-Isovaline, 3-hydroxy-, ethyl ester, (4R)-rel- (9CI)(CAS DataBase Reference)
NIST Chemistry Reference: D-Isovaline, 3-hydroxy-, ethyl ester, (4R)-rel- (9CI)(188124-80-3)
EPA Substance Registry System: D-Isovaline, 3-hydroxy-, ethyl ester, (4R)-rel- (9CI)(188124-80-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 188124-80-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

188124-80-3 Suppliers

Recommended suppliersmore

188124-80-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 188124-80-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,8,1,2 and 4 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 188124-80:
(8*1)+(7*8)+(6*8)+(5*1)+(4*2)+(3*4)+(2*8)+(1*0)=153
153 % 10 = 3
So 188124-80-3 is a valid CAS Registry Number.

188124-80-3Upstream product

188124-80-3Downstream Products

188124-80-3Relevant articles and documents

BENZAMIDINE DERIVATIVES SUBSTITUTED BY AMINO ACID AND HYDROXY ACID DERIVATIVES AND THEIR USE AS ANTI-COAGULANTS

-

, (2008/06/13)

This invention is directed to benzamidine derivatives substituted by amino acid and hydroxy acid derivatives which are useful as anti-coagulants. This invention is also directed to pharmaceutical compositions containing the compounds of the invention, and methods of using the compounds to treat disease-states characterized by thrombotic activity.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 188124-80-3